Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Matrix completes enrollment in IntraDose trials

Sep. 16, 1998

Corixa's MUC-1 vaccine technology receives patent protection

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

Onyx discovers another therapeutic virus for cancer therapy

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

rAd/p21: an effective gene therapy approach for treating lung cancer

Sep. 15, 1998

Japanese researchers report progress in the gene therapy of gastric cancer

Sep. 14, 1998

FDA recommends full approval of first new treatment for metastatic colorectal cancer in 40 years

Sep. 11, 1998

DDE-131: new apoptosis-inducing antitumor agent from WHI

Sep. 11, 1998

Natural nonpeptide inhibitors of protein farnesyltransferase discovered at Merck & Co.

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...